Search results
Results from the WOW.Com Content Network
eBioMedicine is a peer-reviewed open access medical journal initially launched by Elsevier, shortly thereafter supported by Cell Press and The Lancet, and in 2018 incorporated in The Lancet family journals, at the occasion of the inception of its sister journal eClinicalMedicine (Impact Factor 17.033), also published by The Lancet. [1]
The journal was published by Wiley-Blackwell together with the European Molecular Biology Organization since its launch in 2009, until December 2013, when EMBO Press was started. [1] According to the Journal Citation Reports, the journal had a 2023 impact factor of 9.0. [2]
Cancer is a biweekly peer-reviewed scientific journal covering oncology. The journal was established in 1948. It is an official journal of the American Cancer Society and is published by Wiley-Blackwell on behalf of the society. The first editor-in-chief was Fred W. Stewart, who held that position until 1961.
Cancer Informatics; Computational and Structural Biotechnology Journal; Computational Biology and Chemistry; Computers in Biology and Medicine; Current Bioinformatics;
It is affiliated with the African Organization for Research and Training in Cancer. The editors-in-chief are Franco M. Buonaguro (Istituto Nazionale Tumori), Sam M. Mbulaiteye (National Cancer Institute) and Maria Lina Tornesello (Istituto Nazionale Tumori). According to the Journal Citation Reports, the journal has a 2021 impact factor of 3. ...
Cancer Medicine is a monthly peer-reviewed open-access medical journal covering oncology. It was established in 2012 and is published by John Wiley & Sons. The editor-in-chief is Stephen Tait (Institute of Cancer Sciences, University of Glasgow). According to the Journal Citation Reports, the journal has a 2020 impact factor of 4.452. [1]
Cancer Discovery is a monthly peer-reviewed medical journal published by the American Association for Cancer Research. It covers research and clinical trials related to the study of cancer. The editors-in-chief are Lewis C. Cantley and Luis A. Diaz. [1] The journal was established in 2011. [1]
Cancer Cell is internationally regarded as one of the top cancer research and oncology journals. According to the Journal Citation Reports, the 2022 impact factor of the journal is 50.3. It is part of the Cell Press portfolio, which is owned by Elsevier. Issues are published monthly in print and online versions.